APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Contrast Agent Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchOral Contrast Agent Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contrast Agent Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contrast Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contrast Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contrast Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Contrast Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Contrast Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Contrast Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Contrast Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Contrast Agent include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Contrast Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Contrast Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Contrast Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Contrast Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Contrast Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Contrast Agent sales, projected growth trends, production technology, application and end-user industry.

Oral Contrast Agent Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Oral Contrast Agent Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Oral Contrast Agent Segment by Application

Cardiovascular Disorders

Gastrointestinal Disorders

Nephrological Disorders

Neurological Disorders

Musculoskeletal Disorders

Cancer

Oral Contrast Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Contrast Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Contrast Agent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Contrast Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microbubble Contrast Media Major Manufacturers Table 3. Gadolinium-based Contrast Media Major Manufacturers Table 4. Iodinated Contrast Media Major Manufacturers Table 5. Barium-based Contrast Media Major Manufacturers Table 6. Global Oral Contrast Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Cardiovascular Disorders Major Manufacturers Table 8. Gastrointestinal Disorders Major Manufacturers Table 9. Nephrological Disorders Major Manufacturers Table 10. Neurological Disorders Major Manufacturers Table 11. Musculoskeletal Disorders Major Manufacturers Table 12. Cancer Major Manufacturers Table 13. Oral Contrast Agent Industry Trends Table 14. Oral Contrast Agent Industry Drivers Table 15. Oral Contrast Agent Industry Opportunities and Challenges Table 16. Oral Contrast Agent Industry Restraints Table 17. Global Oral Contrast Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Oral Contrast Agent Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Oral Contrast Agent Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Oral Contrast Agent Revenue Market Share by Region (2021-2026) Table 21. Global Oral Contrast Agent Revenue Market Share by Region (2027-2032) Table 22. Global Oral Contrast Agent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Units) Table 24. Global Oral Contrast Agent Sales by Region (2027-2032) & (K Units) Table 25. Global Oral Contrast Agent Sales Market Share by Region (2021-2026) Table 26. Global Oral Contrast Agent Sales Market Share by Region (2027-2032) Table 27. Global Oral Contrast Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Oral Contrast Agent Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Oral Contrast Agent Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Oral Contrast Agent Sales Market Share by Manufacturers (2021-2026) Table 31. Global Oral Contrast Agent Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Oral Contrast Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Oral Contrast Agent Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Oral Contrast Agent Manufacturers, Product Type & Application Table 35. Global Oral Contrast Agent Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Oral Contrast Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Oral Contrast Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Oral Contrast Agent Revenue Market Share by Type (2021-2026) Table 42. Global Oral Contrast Agent Revenue Market Share by Type (2027-2032) Table 43. Global Oral Contrast Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 45. Global Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 46. Global Oral Contrast Agent Sales Market Share by Type (2021-2026) Table 47. Global Oral Contrast Agent Sales Market Share by Type (2027-2032) Table 48. Global Oral Contrast Agent Price by Type (2021-2026) & (US$/Unit) Table 49. Global Oral Contrast Agent Price by Type (2027-2032) & (US$/Unit) Table 50. Global Oral Contrast Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Oral Contrast Agent Revenue Market Share by Application (2021-2026) Table 54. Global Oral Contrast Agent Revenue Market Share by Application (2027-2032) Table 55. Global Oral Contrast Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 57. Global Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 58. Global Oral Contrast Agent Sales Market Share by Application (2021-2026) Table 59. Global Oral Contrast Agent Sales Market Share by Application (2027-2032) Table 60. Global Oral Contrast Agent Price by Application (2021-2026) & (US$/Unit) Table 61. Global Oral Contrast Agent Price by Application (2027-2032) & (US$/Unit) Table 62. Daiichi Sankyo (Japan) Company Information Table 63. Daiichi Sankyo (Japan) Business Overview Table 64. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio Table 66. Daiichi Sankyo (Japan) Recent Development Table 67. Bayer HealthCare (Germany) Company Information Table 68. Bayer HealthCare (Germany) Business Overview Table 69. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio Table 71. Bayer HealthCare (Germany) Recent Development Table 72. Unijules Life Sciences (India) Company Information Table 73. Unijules Life Sciences (India) Business Overview Table 74. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio Table 76. Unijules Life Sciences (India) Recent Development Table 77. Taejoon Pharm (South Korea) Company Information Table 78. Taejoon Pharm (South Korea) Business Overview Table 79. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio Table 81. Taejoon Pharm (South Korea) Recent Development Table 82. Spago Nanomedicine (Sweden) Company Information Table 83. Spago Nanomedicine (Sweden) Business Overview Table 84. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio Table 86. Spago Nanomedicine (Sweden) Recent Development Table 87. Magnus Health (India) Company Information Table 88. Magnus Health (India) Business Overview Table 89. Magnus Health (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Magnus Health (India) Oral Contrast Agent Product Portfolio Table 91. Magnus Health (India) Recent Development Table 92. Lantheus (US) Company Information Table 93. Lantheus (US) Business Overview Table 94. Lantheus (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lantheus (US) Oral Contrast Agent Product Portfolio Table 96. Lantheus (US) Recent Development Table 97. Jodas (India) Company Information Table 98. Jodas (India) Business Overview Table 99. Jodas (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jodas (India) Oral Contrast Agent Product Portfolio Table 101. Jodas (India) Recent Development Table 102. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 103. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 104. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio Table 106. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 107. Guerbet (France) Company Information Table 108. Guerbet (France) Business Overview Table 109. Guerbet (France) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Guerbet (France) Oral Contrast Agent Product Portfolio Table 111. Guerbet (France) Recent Development Table 112. GE Healthcare (US) Company Information Table 113. GE Healthcare (US) Business Overview Table 114. GE Healthcare (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GE Healthcare (US) Oral Contrast Agent Product Portfolio Table 116. GE Healthcare (US) Recent Development Table 117. Bracco Imaging (Italy) Company Information Table 118. Bracco Imaging (Italy) Business Overview Table 119. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio Table 121. Bracco Imaging (Italy) Recent Development Table 122. North America Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 125. North America Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 126. North America Oral Contrast Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Oral Contrast Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 131. North America Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 132. North America Oral Contrast Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Oral Contrast Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Oral Contrast Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Oral Contrast Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 139. North America Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 140. North America Oral Contrast Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Oral Contrast Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 143. Canada Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 144. Europe Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 147. Europe Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 148. Europe Oral Contrast Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Europe Oral Contrast Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Europe Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 153. Europe Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 154. Europe Oral Contrast Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Europe Oral Contrast Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Europe Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Oral Contrast Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Oral Contrast Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Europe Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 161. Europe Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 162. Europe Oral Contrast Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Europe Oral Contrast Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Germany Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 165. France Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 166. U.K. Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 167. Italy Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 169. China Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 170. China Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 171. China Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 172. China Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 173. China Oral Contrast Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 174. China Oral Contrast Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 175. China Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 176. China Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 177. China Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 178. China Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 179. China Oral Contrast Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 180. China Oral Contrast Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 184. Asia Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 185. Asia Oral Contrast Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Asia Oral Contrast Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Asia Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 190. Asia Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 191. Asia Oral Contrast Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Asia Oral Contrast Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Asia Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Oral Contrast Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Oral Contrast Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Asia Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 198. Asia Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 199. Asia Oral Contrast Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Asia Oral Contrast Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Japan Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 202. South Korea Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 203. India Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 204. Australia Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 205. China Taiwan Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 210. SAMEA Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 211. SAMEA Oral Contrast Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 212. SAMEA Oral Contrast Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 213. SAMEA Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 216. SAMEA Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 217. SAMEA Oral Contrast Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 218. SAMEA Oral Contrast Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 219. SAMEA Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Oral Contrast Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Oral Contrast Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. SAMEA Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 224. SAMEA Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 225. SAMEA Oral Contrast Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 226. SAMEA Oral Contrast Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 227. Brazil Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 228. Argentina Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 229. Chile Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 230. Colombia Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 231. Peru Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 233. Israel Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 234. UAE Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 235. Turkey Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 236. Iran Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 237. Egypt Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Oral Contrast Agent Distributors List Table 241. Oral Contrast Agent Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Oral Contrast Agent Image Figure 2. Global Oral Contrast Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contrast Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microbubble Contrast Media Image Figure 5. Gadolinium-based Contrast Media Image Figure 6. Iodinated Contrast Media Image Figure 7. Barium-based Contrast Media Image Figure 8. Global Oral Contrast Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Oral Contrast Agent Market Size Share 2021 VS 2025 VS 2032 Figure 10. Cardiovascular Disorders Image Figure 11. Gastrointestinal Disorders Image Figure 12. Nephrological Disorders Image Figure 13. Neurological Disorders Image Figure 14. Musculoskeletal Disorders Image Figure 15. Cancer Image Figure 16. Global Oral Contrast Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Figure 18. Global Oral Contrast Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Oral Contrast Agent Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Oral Contrast Agent Revenue Market Share by Region (2021-2032) Figure 21. Global Oral Contrast Agent Sales (2021-2032) & (K Units) Figure 22. Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Oral Contrast Agent Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Oral Contrast Agent Sales YoY (2021-2032) & (K Units) Figure 25. Europe Oral Contrast Agent Sales YoY (2021-2032) & (K Units) Figure 26. China Oral Contrast Agent Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Oral Contrast Agent Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Oral Contrast Agent Sales YoY (2021-2032) & (K Units) Figure 29. Global Oral Contrast Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Oral Contrast Agent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Oral Contrast Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oral Contrast Agent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Oral Contrast Agent Revenue Market Share by Type (2021-2032) Figure 35. Global Oral Contrast Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Oral Contrast Agent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Oral Contrast Agent Sales Market Share by Type (2021-2032) Figure 38. Global Oral Contrast Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Oral Contrast Agent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Oral Contrast Agent Revenue Market Share by Application (2021-2032) Figure 41. Global Oral Contrast Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Oral Contrast Agent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Oral Contrast Agent Sales Market Share by Application (2021-2032) Figure 44. North America Oral Contrast Agent Revenue Share by Type (2021-2032) Figure 45. North America Oral Contrast Agent Sales Share by Type (2021-2032) Figure 46. North America Oral Contrast Agent Revenue Share by Application (2021-2032) Figure 47. North America Oral Contrast Agent Sales Share by Application (2021-2032) Figure 48. North America Oral Contrast Agent Revenue Share by Country (2021-2032) Figure 49. North America Oral Contrast Agent Sales Share by Country (2021-2032) Figure 50. Europe Oral Contrast Agent Revenue Share by Type (2021-2032) Figure 51. Europe Oral Contrast Agent Sales Share by Type (2021-2032) Figure 52. Europe Oral Contrast Agent Revenue Share by Application (2021-2032) Figure 53. Europe Oral Contrast Agent Sales Share by Application (2021-2032) Figure 54. Europe Oral Contrast Agent Revenue Share by Country (2021-2032) Figure 55. Europe Oral Contrast Agent Sales Share by Country (2021-2032) Figure 56. China Oral Contrast Agent Revenue Share by Type (2021-2032) Figure 57. China Oral Contrast Agent Sales Share by Type (2021-2032) Figure 58. China Oral Contrast Agent Revenue Share by Application (2021-2032) Figure 59. China Oral Contrast Agent Sales Share by Application (2021-2032) Figure 60. Asia Oral Contrast Agent Revenue Share by Type (2021-2032) Figure 61. Asia Oral Contrast Agent Sales Share by Type (2021-2032) Figure 62. Asia Oral Contrast Agent Revenue Share by Application (2021-2032) Figure 63. Asia Oral Contrast Agent Sales Share by Application (2021-2032) Figure 64. Asia Oral Contrast Agent Revenue Share by Country (2021-2032) Figure 65. Asia Oral Contrast Agent Sales Share by Country (2021-2032) Figure 66. SAMEA Oral Contrast Agent Revenue Share by Type (2021-2032) Figure 67. SAMEA Oral Contrast Agent Sales Share by Type (2021-2032) Figure 68. SAMEA Oral Contrast Agent Revenue Share by Application (2021-2032) Figure 69. SAMEA Oral Contrast Agent Sales Share by Application (2021-2032) Figure 70. SAMEA Oral Contrast Agent Revenue Share by Country (2021-2032) Figure 71. SAMEA Oral Contrast Agent Sales Share by Country (2021-2032) Figure 72. Oral Contrast Agent Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Oral Contrast Agent Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cancer
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Contrast Agent Market by Type
  3. 1.2.1 Global Oral Contrast Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microbubble Contrast Media
  5. 1.2.3 Gadolinium-based Contrast Media
  6. 1.2.4 Iodinated Contrast Media
  7. 1.2.5 Barium-based Contrast Media
  8. 1.3 Oral Contrast Agent Market by Application
  9. 1.3.1 Global Oral Contrast Agent Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Cardiovascular Disorders
  11. 1.3.3 Gastrointestinal Disorders
  12. 1.3.4 Nephrological Disorders
  13. 1.3.5 Neurological Disorders
  14. 1.3.6 Musculoskeletal Disorders
  15. 1.3.7 Cancer
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Oral Contrast Agent Market Dynamics
  1. 2.1 Oral Contrast Agent Industry Trends
  2. 2.2 Oral Contrast Agent Industry Drivers
  3. 2.3 Oral Contrast Agent Industry Opportunities and Challenges
  4. 2.4 Oral Contrast Agent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Contrast Agent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Contrast Agent Revenue by Region
  3. 3.2.1 Global Oral Contrast Agent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Contrast Agent Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Contrast Agent Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Contrast Agent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Contrast Agent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Contrast Agent Sales by Region
  9. 3.4.1 Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Contrast Agent Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Contrast Agent Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Contrast Agent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Contrast Agent Revenue by Manufacturers
  2. 4.1.1 Global Oral Contrast Agent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Contrast Agent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Contrast Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Contrast Agent Sales by Manufacturers
  6. 4.2.1 Global Oral Contrast Agent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Contrast Agent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Contrast Agent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Contrast Agent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Contrast Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Contrast Agent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Contrast Agent Manufacturers, Product Type & Application
  13. 4.7 Global Oral Contrast Agent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Contrast Agent Market CR5 and HHI
  16. 4.8.2 2025 Oral Contrast Agent Tier 1, Tier 2, and Tier 3
5 Oral Contrast Agent Market by Type
  1. 5.1 Global Oral Contrast Agent Revenue by Type
  2. 5.1.1 Global Oral Contrast Agent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Contrast Agent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Contrast Agent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Contrast Agent Sales by Type
  6. 5.2.1 Global Oral Contrast Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Contrast Agent Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oral Contrast Agent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Contrast Agent Price by Type
6 Oral Contrast Agent Market by Application
  1. 6.1 Global Oral Contrast Agent Revenue by Application
  2. 6.1.1 Global Oral Contrast Agent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Contrast Agent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Contrast Agent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Contrast Agent Sales by Application
  6. 6.2.1 Global Oral Contrast Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Contrast Agent Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oral Contrast Agent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Contrast Agent Price by Application
7 Company Profiles
  1. 7.1 Daiichi Sankyo (Japan)
  2. 7.1.1 Daiichi Sankyo (Japan) Company Information
  3. 7.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 7.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
  6. 7.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 7.2 Bayer HealthCare (Germany)
  8. 7.2.1 Bayer HealthCare (Germany) Company Information
  9. 7.2.2 Bayer HealthCare (Germany) Business Overview
  10. 7.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
  12. 7.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 7.3 Unijules Life Sciences (India)
  14. 7.3.1 Unijules Life Sciences (India) Company Information
  15. 7.3.2 Unijules Life Sciences (India) Business Overview
  16. 7.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
  18. 7.3.5 Unijules Life Sciences (India) Recent Developments
  19. 7.4 Taejoon Pharm (South Korea)
  20. 7.4.1 Taejoon Pharm (South Korea) Company Information
  21. 7.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 7.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
  24. 7.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 7.5 Spago Nanomedicine (Sweden)
  26. 7.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 7.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 7.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
  30. 7.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 7.6 Magnus Health (India)
  32. 7.6.1 Magnus Health (India) Company Information
  33. 7.6.2 Magnus Health (India) Business Overview
  34. 7.6.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
  36. 7.6.5 Magnus Health (India) Recent Developments
  37. 7.7 Lantheus (US)
  38. 7.7.1 Lantheus (US) Company Information
  39. 7.7.2 Lantheus (US) Business Overview
  40. 7.7.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
  42. 7.7.5 Lantheus (US) Recent Developments
  43. 7.8 Jodas (India)
  44. 7.8.1 Jodas (India) Company Information
  45. 7.8.2 Jodas (India) Business Overview
  46. 7.8.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
  48. 7.8.5 Jodas (India) Recent Developments
  49. 7.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 7.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 7.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 7.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
  54. 7.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 7.10 Guerbet (France)
  56. 7.10.1 Guerbet (France) Company Information
  57. 7.10.2 Guerbet (France) Business Overview
  58. 7.10.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
  60. 7.10.5 Guerbet (France) Recent Developments
  61. 7.11 GE Healthcare (US)
  62. 7.11.1 GE Healthcare (US) Company Information
  63. 7.11.2 GE Healthcare (US) Business Overview
  64. 7.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
  66. 7.11.5 GE Healthcare (US) Recent Developments
  67. 7.12 Bracco Imaging (Italy)
  68. 7.12.1 Bracco Imaging (Italy) Company Information
  69. 7.12.2 Bracco Imaging (Italy) Business Overview
  70. 7.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
  72. 7.12.5 Bracco Imaging (Italy) Recent Developments
8 North America
  1. 8.1 North America Oral Contrast Agent Market Size by Type
  2. 8.1.1 North America Oral Contrast Agent Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Contrast Agent Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Contrast Agent Price by Type (2021-2032)
  5. 8.2 North America Oral Contrast Agent Market Size by Application
  6. 8.2.1 North America Oral Contrast Agent Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Contrast Agent Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Contrast Agent Price by Application (2021-2032)
  9. 8.3 North America Oral Contrast Agent Market Size by Country
  10. 8.3.1 North America Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Contrast Agent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Oral Contrast Agent Market Size by Type
  2. 9.1.1 Europe Oral Contrast Agent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Contrast Agent Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Contrast Agent Price by Type (2021-2032)
  5. 9.2 Europe Oral Contrast Agent Market Size by Application
  6. 9.2.1 Europe Oral Contrast Agent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Contrast Agent Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Contrast Agent Price by Application (2021-2032)
  9. 9.3 Europe Oral Contrast Agent Market Size by Country
  10. 9.3.1 Europe Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Contrast Agent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Oral Contrast Agent Market Size by Type
  2. 10.1.1 China Oral Contrast Agent Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Contrast Agent Sales by Type (2021-2032)
  4. 10.1.3 China Oral Contrast Agent Price by Type (2021-2032)
  5. 10.2 China Oral Contrast Agent Market Size by Application
  6. 10.2.1 China Oral Contrast Agent Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Contrast Agent Sales by Application (2021-2032)
  8. 10.2.3 China Oral Contrast Agent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Contrast Agent Market Size by Type
  2. 11.1.1 Asia Oral Contrast Agent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Contrast Agent Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Contrast Agent Price by Type (2021-2032)
  5. 11.2 Asia Oral Contrast Agent Market Size by Application
  6. 11.2.1 Asia Oral Contrast Agent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Contrast Agent Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Contrast Agent Price by Application (2021-2032)
  9. 11.3 Asia Oral Contrast Agent Market Size by Country
  10. 11.3.1 Asia Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Contrast Agent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Contrast Agent Market Size by Type
  2. 12.1.1 SAMEA Oral Contrast Agent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Contrast Agent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Contrast Agent Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Contrast Agent Market Size by Application
  6. 12.2.1 SAMEA Oral Contrast Agent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Contrast Agent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Contrast Agent Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Contrast Agent Market Size by Country
  10. 12.3.1 SAMEA Oral Contrast Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Contrast Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Contrast Agent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Contrast Agent Value Chain Analysis
  2. 13.1.1 Oral Contrast Agent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Contrast Agent Production Mode & Process
  6. 13.2 Oral Contrast Agent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Contrast Agent Distributors
  9. 13.2.3 Oral Contrast Agent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst